The 11+ exam is a major milestone in a child’s academic journey, often determining their admission into some of the UK’s most prestigious grammar schools. With competition increasing every year, the ...

The band are now one of the biggest music acts in the world, but ahead of next month’s Lido festival, frontwoman Hannah Reid ...

News that former President Biden’s diagnosis of an aggressive form that has spread to his bones is a wake call for many men. Internal Medicine Specialist Dr. Justin Turner with Turner Care sees about ...

In this interview, Dr Ryan Stidham discusses the various ways in which artificial intelligence is being used to streamline ...

Shane and Gillian are at the forefront of the fundraising and they’ll earn every penny they raise when they take on the ...

The FDA cleared the first blood-based in vitro diagnostic test for Alzheimer's disease, the agency announced Friday. The blood test, known as the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio ...

The test, manufactured by Fujirebio Diagnostics, is for those aged 55 and older who are already exhibiting signs and symptoms of the disease, the agency said. Alzheimer's disease is a ...

The Food and Drug Administration cleared a blood test that measures biomarkers to inform the diagnosis of Alzheimer’s disease, the agency said Friday. Fujirebio Diagnostics received the 510(k ...

The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s disease, the first diagnostic tool that uses a blood draw to check for ...

The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is not intended as a screening or stand-alone diagnostic test and other clinical evaluations or additional tests should be used for ...

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker for Alzheimer’s. Previously, the only FDA-approved methods for detecting ...